Home » Stocks » BioVie

BioVie, Inc. (BIVI)

Stock Price: $9.06 USD -0.12 (-1.31%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 63.48M
Revenue (ttm) n/a
Net Income (ttm) -16.68M
Shares Out 7.01M
EPS (ttm) -6.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $9.06
Previous Close $9.18
Change ($) -0.12
Change (%) -1.31%
Day's Open 9.22
Day's Range 9.00 - 9.25
Day's Volume 9,099
52-Week Range 2.20 - 34.54

More Stats

Market Cap 63.48M
Enterprise Value 64.35M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 7.01M
Float 1.25M
EPS (basic) -6.85
EPS (diluted) -6.85
FCF / Share -0.33
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 4,917
Short Ratio 0.11
Short % of Float 0.39%
Beta 2.66
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 13.99
Revenue n/a
Operating Income -2.69M
Net Income -16.68M
Free Cash Flow -1.63M
Net Cash -873,848
Net Cash / Share -0.12
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -72.26%
ROE 826.55%
ROIC 117.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-2.69-2.50-2.37-1.55-0.43-0.23-0.32
Net Income-16.68-2.44-2.41-1.33-0.43-0.23-0.32
Shares Outstanding4.932.540.770.720.700.700.70
Earnings Per Share-6.85-0.98-3.75-1.25---
Operating Cash Flow-1.63-2.50-0.62-0.62-0.15-0.07-0.17
Free Cash Flow-1.63-2.50-0.62-0.62-0.15-0.07-0.17
Cash & Equivalents0.040.340.
Total Debt0.91-0.830.610.01--
Net Cash / Debt-0.870.34-0.78-0.610.110.270.33
Book Value-21.502.
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name BioVie, Inc.
Country United States
Employees 2
CEO Terren S. Peizer

Stock Information

Ticker Symbol BIVI
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: BIVI


BioVie, a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. It develops BIV201, which completed Phase 2a clinical trial for the treatment of ascites due to chronic liver cirrhosis. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was founded in 2013 and is based in Santa Monica, California.